Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 368

1.

In Vitro Thrombogenicity Testing of Biomaterials.

Braune S, Latour RA, Reinthaler M, Landmesser U, Lendlein A, Jung F.

Adv Healthc Mater. 2019 Oct 15:e1900527. doi: 10.1002/adhm.201900527. [Epub ahead of print] Review.

PMID:
31612646
2.

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH; Conference Participants.

J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. doi: 10.1016/j.jacc.2019.08.1017. Review.

3.

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table.

Doehner W, Mazighi M, Hofmann BM, Lautsch D, Hindricks G, Bohula EA, Byrne RA, Camm AJ, Casadei B, Caso V, Cognard C, Diener HC, Endres M, Goldstein P, Halliday A, Hopewell JC, Jovanovic DR, Kobayashi A, Kostrubiec M, Krajina A, Landmesser U, Markus HS, Ntaios G, Pezzella FR, Ribo M, Rosano GM, Rubiera M, Sharma M, Touyz RM, Widimsky P.

Eur J Prev Cardiol. 2019 Sep 30:2047487319873460. doi: 10.1177/2047487319873460. [Epub ahead of print]

PMID:
31569966
4.

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial.

Ray KK, Stoekenbroek RM, Kallend D, Nishikido T, Leiter LA, Landmesser U, Wright RS, Wijngaard PLJ, Kastelein JJP.

JAMA Cardiol. 2019 Sep 25. doi: 10.1001/jamacardio.2019.3502. [Epub ahead of print]

PMID:
31553410
5.

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ; Conference Participants.

Kidney Int. 2019 Oct;96(4):836-849. doi: 10.1016/j.kint.2019.06.025.

6.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz455. doi: 10.1093/eurheartj/ehz455. [Epub ahead of print] No abstract available.

PMID:
31504418
7.

Cohort profile: role of lipoproteins in cardiovascular disease-the LipidCardio study.

König M, Joshi S, Leistner DM, Landmesser U, Sinning D, Steinhagen-Thiessen E, Demuth I.

BMJ Open. 2019 Sep 3;9(9):e030097. doi: 10.1136/bmjopen-2019-030097.

8.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators.

N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1.

PMID:
31475799
9.

Clinical Presentation and Laboratory Findings in Men Versus Women with Myocarditis.

Patriki D, Kottwitz J, Berg J, Landmesser U, Lüscher TF, Heidecker B.

J Womens Health (Larchmt). 2019 Aug 29. doi: 10.1089/jwh.2018.7618. [Epub ahead of print]

PMID:
31464553
10.

Procedural and clinical performance of dual- versus single-catheter strategy for transradial coronary angiography: A meta-analysis of randomized trials.

Alushi B, Lauten A, Ndrepepa G, Leistner DM, Kufner S, Xhepa E, Landmesser U, Kastrati A, Cassese S.

Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28458. [Epub ahead of print]

PMID:
31448867
11.

The Authors' Reply.

Alushi B, Landmesser U, Falk V, Lauten A.

JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1294-1296. doi: 10.1016/j.jcmg.2019.05.010. No abstract available.

PMID:
31272610
12.

Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study.

Heidecker B, Ruedi G, Baltensperger N, Gresser E, Kottwitz J, Berg J, Manka R, Landmesser U, Lüscher TF, Patriki D.

Swiss Med Wkly. 2019 Jul 3;149:w20098. doi: 10.4414/smw.2019.20098. eCollection 2019 Jul 1.

13.

Association of the body mass index with outcomes in elderly patients (≥80 years) undergoing percutaneous coronary intervention.

Leistner DM, Bazara S, Münch C, Steiner J, Erbay A, Siegrist PT, Skurk C, Lauten A, Müller-Werdan U, Landmesser U, Stähli BE.

Int J Cardiol. 2019 Oct 1;292:73-77. doi: 10.1016/j.ijcard.2019.06.044. Epub 2019 Jun 19.

PMID:
31256990
14.

Correlation of P-wave properties with the size of left atrial low voltage areas in patients with atrial fibrillation.

Schreiber T, Kähler N, Tscholl V, Nagel P, Blaschke F, Landmesser U, Attanasio P, Huemer M.

J Electrocardiol. 2019 Sep - Oct;56:38-42. doi: 10.1016/j.jelectrocard.2019.06.008. Epub 2019 Jun 21.

PMID:
31255952
15.

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.

Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, Anand A, Boeddinghaus J, Nestelberger T, Badertscher P, Mokhtari A, Pickering JW, Troughton RW, Greenslade J, Parsonage W, Mueller-Hennessen M, Gori T, Jernberg T, Morris N, Liebetrau C, Hamm C, Katus HA, Münzel T, Landmesser U, Salomaa V, Iacoviello L, Ferrario MM, Giampaoli S, Kee F, Thorand B, Peters A, Borchini R, Jørgensen T, Söderberg S, Sans S, Tunstall-Pedoe H, Kuulasmaa K, Renné T, Lackner KJ, Worster A, Body R, Ekelund U, Kavsak PA, Keller T, Lindahl B, Wild P, Giannitsis E, Than M, Cullen LA, Mills NL, Mueller C, Zeller T, Westermann D, Blankenberg S.

N Engl J Med. 2019 Jun 27;380(26):2529-2540. doi: 10.1056/NEJMoa1803377.

PMID:
31242362
16.

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock.

Alushi B, Douedari A, Froehlig G, Knie W, Wurster TH, Leistner DM, Stahli BE, Mochmann HC, Pieske B, Landmesser U, Krackhardt F, Skurk C.

Open Heart. 2019 May 13;6(1):e000987. doi: 10.1136/openhrt-2018-000987. eCollection 2019. Erratum in: Open Heart. 2019 Jun 24;6(1):e000987corr1.

17.

Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up.

Berg J, Lovrinovic M, Baltensperger N, Kissel CK, Kottwitz J, Manka R, Patriki D, Scherff F, Schmied C, Landmesser U, Lüscher TF, Heidecker B.

Open Heart. 2019 Apr 23;6(1):e000990. doi: 10.1136/openhrt-2018-000990. eCollection 2019.

18.

[Left atrial appendage closure in non-valvular atrial fibrillation].

Häusler KG, Landmesser U.

Herz. 2019 Jun;44(4):310-314. doi: 10.1007/s00059-019-4812-9. Review. German.

PMID:
31076823
19.

Is There a Need to Revise Goals in the Management of Dyslipidemias?

Sinning D, Landmesser U.

Curr Cardiol Rep. 2019 Apr 30;21(6):51. doi: 10.1007/s11886-019-1128-6. Review.

PMID:
31041621
20.

Cardiac Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke and Elevated Troponin: A TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Sub-Study.

Haeusler KG, Jensen C, Scheitz JF, Krause T, Wollboldt C, Witzenbichler B, Audebert HJ, Landmesser U, Fiebach JB, Nolte CH, Endres M, Mochmann HC.

Cerebrovasc Dis Extra. 2019 Apr 30;9(1):19-24. doi: 10.1159/000498864. [Epub ahead of print]

21.

Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry.

Cruz-González I, González-Ferreiro R, Freixa X, Gafoor S, Shakir S, Omran H, Berti S, Santoro G, Kefer J, Landmesser U, Nielsen-Kudsk JE, Kanagaratnam P, Nietlispach F, Gloekler S, Aminian A, Danna P, Rezzaghi M, Stock F, Stolcova M, Paiva L, Costa M, Millán X, Ibrahim R, Tichelbäcker T, Schillinger W, Park JW, Sievert H, Meier B, Tzikas A.

Rev Esp Cardiol (Engl Ed). 2019 Apr 27. pii: S1885-5857(19)30055-6. doi: 10.1016/j.rec.2019.02.013. [Epub ahead of print] English, Spanish.

PMID:
31036510
22.

Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.

Tang WHW, Bäckhed F, Landmesser U, Hazen SL.

J Am Coll Cardiol. 2019 Apr 30;73(16):2089-2105. doi: 10.1016/j.jacc.2019.03.024. Review.

PMID:
31023434
23.

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.

Friebel J, Weithauser A, Witkowski M, Rauch BH, Savvatis K, Dörner A, Tabaraie T, Kasner M, Moos V, Bösel D, Gotthardt M, Radke MH, Wegner M, Bobbert P, Lassner D, Tschöpe C, Schutheiss HP, Felix SB, Landmesser U, Rauch U.

Eur Heart J. 2019 Apr 19. pii: ehz117. doi: 10.1093/eurheartj/ehz117. [Epub ahead of print]

PMID:
31004144
24.

Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients.

Gast M, Rauch B, Haghikia A, Nakagawa S, Haas J, Stroux A, Schmidt D, Schumann P, Weiss S, Jensen L, Kratzer A, Kraenkel N, Müller C, Börnigen D, Hirose T, Blankenberg S, Escher F, Kühl A, Kuss A, Meder B, Landmesser U, Zeller T, Poller W.

Cardiovasc Res. 2019 Mar 29. pii: cvz085. doi: 10.1093/cvr/cvz085. [Epub ahead of print]

PMID:
30924864
25.

Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.

Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJS, Anker SD.

J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):22-34. doi: 10.1002/jcsm.12402.

26.

Effect on Outcomes: Infections Complicating Percutaneous Coronary Interventions in Patients ≥80 Years of Age.

Leistner DM, Münch C, Steiner J, Lauten A, Landmesser U, Stähli BE.

Am J Cardiol. 2019 Jun 1;123(11):1806-1811. doi: 10.1016/j.amjcard.2019.03.003. Epub 2019 Mar 9.

PMID:
30910227
27.

Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.

Wernly B, Seelmaier C, Leistner D, Stähli BE, Pretsch I, Lichtenauer M, Jung C, Hoppe UC, Landmesser U, Thiele H, Lauten A.

Clin Res Cardiol. 2019 Mar 21. doi: 10.1007/s00392-019-01458-2. [Epub ahead of print]

PMID:
30900010
28.

Velocity characteristics of atrial fibrillation sources determined by electrographic flow mapping before and after catheter ablation.

Bellmann B, Zettwitz M, Lin T, Ruppersberg P, Guttmann S, Tscholl V, Nagel P, Roser M, Landmesser U, Rillig A.

Int J Cardiol. 2019 Jul 1;286:56-60. doi: 10.1016/j.ijcard.2019.02.006. Epub 2019 Feb 11.

PMID:
30773268
29.

Transcatheter aortic valve replacement for pure aortic valve regurgitation: "on-label" versus "off-label" use of TAVR devices.

Wernly B, Eder S, Navarese EP, Kretzschmar D, Franz M, Alushi B, Beckhoff F, Jung C, Lichtenauer M, Datz C, Schulze PC, Landmesser U, Hoppe UC, Falk V, Lauten A.

Clin Res Cardiol. 2019 Aug;108(8):921-930. doi: 10.1007/s00392-019-01422-0. Epub 2019 Feb 8.

PMID:
30737532
30.

LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

Silbernagel G, Scharnagl H, Kleber ME, Delgado G, Stojakovic T, Laaksonen R, Erdmann J, Rankinen T, Bouchard C, Landmesser U, Schunkert H, März W, Grammer TB.

Atherosclerosis. 2019 Mar;282:37-44. doi: 10.1016/j.atherosclerosis.2018.12.024. Epub 2018 Dec 28.

PMID:
30685440
31.

The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients.

Seiffert M, Walther T, Hamm C, Falk V, Frey N, Thiele H, Hagl C, Landmesser U, Borger M, Massberg S, Reichenspurner H, Baumgartner H, Blankenberg S, Cremer J.

Eur Heart J. 2019 Jan 21;40(4):331-333. doi: 10.1093/eurheartj/ehy851. No abstract available.

PMID:
30668699
32.

Into the Wild: GWAS Exploration of Non-coding RNAs.

Giral H, Landmesser U, Kratzer A.

Front Cardiovasc Med. 2018 Dec 17;5:181. doi: 10.3389/fcvm.2018.00181. eCollection 2018. Review.

33.

Maintaining Cardiovascular Health in the digital era.

Leistner DM, Landmesser U.

Eur Heart J. 2019 Jan 1;40(1):9-12. doi: 10.1093/eurheartj/ehy790. No abstract available.

PMID:
30602010
34.

The year in cardiology 2018: prevention.

Reiner Ž, Laufs U, Cosentino F, Landmesser U.

Eur Heart J. 2019 Jan 21;40(4):336-344. doi: 10.1093/eurheartj/ehy894. No abstract available.

PMID:
30601998
35.

Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Möbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schäfer A, Westermann D.

Circulation. 2019 Mar 5;139(10):1249-1258. doi: 10.1161/CIRCULATIONAHA.118.036614.

PMID:
30586755
36.

Comparison of resting distal to aortic coronary pressure with angiography-based quantitative flow ratio.

Stähli BE, Erbay A, Steiner J, Klotsche J, Mochmann HC, Skurk C, Lauten A, Landmesser U, Leistner DM.

Int J Cardiol. 2019 Mar 15;279:12-17. doi: 10.1016/j.ijcard.2018.11.093. Epub 2018 Nov 17.

PMID:
30545620
37.

Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.

Ariza de Schellenberger A, Poller WC, Stangl V, Landmesser U, Schellenberger E.

Int J Nanomedicine. 2018 Nov 23;13:7905-7913. doi: 10.2147/IJN.S179920. eCollection 2018.

38.

Noninvasive Imaging of Endothelial Damage in Patients With Different HbA1c Levels: A Proof-of-Concept Study.

Engel LC, Landmesser U, Goehler A, Gigengack K, Wurster TH, Manes C, Girke G, Jaguszewski M, Skurk C, Leistner DM, Lauten A, Schuster A, Noutsias M, Hamm B, Botnar RM, Bigalke B, Makowski MR.

Diabetes. 2019 Feb;68(2):387-394. doi: 10.2337/db18-0239. Epub 2018 Nov 28.

39.

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial.

Leiter LA, Teoh H, Kallend D, Wright RS, Landmesser U, Wijngaard PLJ, Kastelein JJP, Ray KK.

Diabetes Care. 2019 Jan;42(1):173-176. doi: 10.2337/dc18-1491. Epub 2018 Nov 28.

40.

[Left atrial appendage occlusion in patients with nonvalvular atrial fibrillation : Present evidence, ongoing studies, open questions].

Häusler KG, Endres M, Landmesser U.

Med Klin Intensivmed Notfmed. 2018 Nov 27. doi: 10.1007/s00063-018-0500-4. [Epub ahead of print] Review. German.

PMID:
30483820
41.

Coronary disease prevention: towards a more personalised approach.

Landmesser U, Catapano A.

Eur J Prev Cardiol. 2018 Nov;25(17):1884-1886. doi: 10.1177/2047487318805578. Epub 2018 Oct 15. No abstract available.

PMID:
30322267
42.

Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.

Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):16-24. doi: 10.1002/ccd.27712. Epub 2018 Oct 5.

PMID:
30291678
43.

A combination of rare complications 3 years after a dual-chamber pacemaker implantation.

Schreiber T, Tscholl V, Niehues SM, Nagel P, Starck CT, Landmesser U, Huemer M, Attanasio P.

Clin Res Cardiol. 2019 May;108(5):465-467. doi: 10.1007/s00392-018-1375-3. Epub 2018 Sep 27.

PMID:
30259106
44.

Increased Expression of miR-483-3p Impairs the Vascular Response to Injury in Type 2 Diabetes.

Kuschnerus K, Straessler ET, Müller MF, Lüscher TF, Landmesser U, Kränkel N.

Diabetes. 2019 Feb;68(2):349-360. doi: 10.2337/db18-0084. Epub 2018 Sep 26.

45.

Performance of One- Compared With Two-Catheter Concepts in Transradial Coronary Angiography (from the Randomized Use of Different Diagnostic Catheters-Radial-Trial).

Schneider VS, Lübking L, Stähli BE, Skurk C, Lauten A, Mochmann HC, Schauerte P, Riedel M, Steinbeck L, Rauch-Kröhnert U, Klotsche J, Landmesser U, Fröhlich G, Leistner DM.

Am J Cardiol. 2018 Nov 15;122(10):1647-1651. doi: 10.1016/j.amjcard.2018.07.039. Epub 2018 Aug 20.

PMID:
30217374
46.

Effect of Physical Disability on Mortality in Elderly Patients of ≥80 Years of Age Undergoing Percutaneous Coronary Intervention.

Leistner DM, Münch C, Steiner J, Jakob P, Reinthaler M, Sinning D, Fröhlich GM, Mochmann HC, Rauch-Kröhnert U, Skurk C, Lauten A, Landmesser U, Stähli BE.

Am J Cardiol. 2018 Aug 15;122(4):537-541. doi: 10.1016/j.amjcard.2018.04.055. Epub 2018 Jun 20.

PMID:
30205884
47.

[Catheter-based atrial appendage closure-current data and future developments].

Skurk C, Hartung JJ, Leistner DM, Landmesser U.

Internist (Berl). 2018 Oct;59(10):1028-1040. doi: 10.1007/s00108-018-0483-5. Review. German.

PMID:
30182193
48.

Correction to: Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves.

Wernly B, Zappe AK, Unbehaun A, Sinning JM, Jung C, Kim WK, Fichtlscherer S, Lichtenauer M, Hoppe UC, Alushi B, Beckhoff F, Wewetzer C, Franz M, Kretzschmar D, Navarese E, Landmesser U, Falk V, Lauten A.

Clin Res Cardiol. 2019 Jan;108(1):117. doi: 10.1007/s00392-018-1350-z.

PMID:
30182163
49.

One-Year Outcomes after PCI Strategies in Cardiogenic Shock.

Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators.

N Engl J Med. 2018 Nov 1;379(18):1699-1710. doi: 10.1056/NEJMoa1808788. Epub 2018 Aug 25.

50.

Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-/-mice.

Gast M, Rauch BH, Nakagawa S, Haghikia A, Jasina A, Haas J, Nath N, Jensen L, Stroux A, Böhm A, Friebel J, Rauch U, Skurk C, Blankenberg S, Zeller T, Prasanth KV, Meder B, Kuss A, Landmesser U, Poller W.

Cardiovasc Res. 2019 Feb 1;115(2):302-314. doi: 10.1093/cvr/cvy202.

PMID:
30101304

Supplemental Content

Loading ...
Support Center